Zeiss Vision Care Unveils Myopia Insights Hub
Zeiss Vision Care has launched the Myopia Insights Hub, an online platform providing regular updates and expert insights on myopia. The Myopia Insights Hub offers the “Newsticker” section, which presents the latest findings from Zeiss’ research and development efforts, including studies on the efficacy of its Zeiss MyoCare portfolio. The hub also includes an “Articles and Insights” section, featuring contributions from leading myopia. Additionally, the hub provides access to resources from the Association for Research in Vision and Ophthalmology (ARVO) and showcases Zeiss Vision Care posters presented at the key industry conference. Finally, the platform features an “Ask an Expert” section, allowing users to engage directly with leading professionals in the field of myopia.
Arcscan’s Insight 100 Ophthalmic Ultrasound Imaging System Approved in China
ArcScan announced that the ArcScan Insight 100 has received National Medical Products Administration (NMPA) approval in China. The Insight 100 is designed to allow eye surgeons to more accurately determine the appropriate sizing of phakic IOLs for placement behind the iris for treatment of myopia. In addition to NMPA certification, The Arcscan Insight 100 has U.S. Food and Drug Administration clearance and CE Mark approval.
Nidek Launches the RS-1 Glauvas Optical Coherence Tomography
Nidek has launched the RS-1 Glauvas Optical Coherence Tomography (OCT). The RS-1 Glauvas has up to 250kHz scan speed, wide and deep area imaging, operability, and deep learning-based analytics. The incorporation of 250,000 A-scans per second accelerates the workflow by reducing capture time. The high-speed imaging also addresses patient fixation errors, thus contributing to greater image clarity and patient comfort, according to Nidek.
The RS-1 Glauvas incorporates various advanced analytics functions for glaucoma and retinal diseases. The long axial length normative database and scan width correction are designed to help with the glaucoma assessment of patients with axial myopia. Deep learning (DL) segmentation reduces artifacts and errors in the normative database and thickness maps, even in eyes with opacities, thus decreasing false positives and enhancing clinic efficiency by reducing unnecessary follow-up visits, Nidek stated. The DL segmentation provides a Structural Normality Map (SN Map) developed in collaboration with Kagoshima University. The SN Map presents structural abnormalities and aids clinicians in detecting minute structural changes at a glance, contributing to greater diagnostic confidence for early signs of retinal changes.